Phase 2 Trial of Single Agent Ifosfamide/Mesna in Patients with Platinum/Paclitaxel Refractory Ovarian Cancer Who Have Not Previously Been Treated with an Alkylating Agent

✍ Scribed by Maurie Markman; Alexander Kennedy; Gregory Sutton; Jean Hurteau; Kenneth Webster; Gertrude Peterson; Barbara Kulp; Jerome Belinson

• Book ID: 112247422
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 48 KB
• Volume: 70
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1006/gyno.1998.5065